THIS IS AN ONLINE E LOG BOOK TO DISCUSS OUR PATIENT'S DE-IDENTIFIED HEALTH DATA SHARED AFTER TAKING HER SIGNED INFORMED CONSENT. HERE WE DISCUSS OUR PATIENT'S PROBLEMS THROUGH SERIES OF INPUTS FROM AVAILABLE GLOBAL ONLINE COMMUNITY EXPERTS WITH AN AIM TO SOLVE THOSE PATIENT'S CLINICAL PROBLEMS WITH COLLECTIVE CURRENT BEST EVIDENCE BASED INPUTS.
[22-08-2025 21:10] PPM 1: [22/08, 20:52] Dhu Edema 24:
Long distance case sir
20 yr old female came with the complaints of abdominal distension since 7 years
C/o facial swelling and pedal edema since 7 years on and off releived by medication
Since childhood she is unable to hear and talk
Since 7 years she has history of fever on and off and relieved by medication
No history of chest pain sob orthopnea pnd, sweating, palpitations
No history of vomiting, loose stools, cold, cough, headache
No history of loc giddiness, weakness of ul and LL
No comorbidities
Bp-110/60mmg
Pr-102bpm
Rr-19cpm
Sp02-97@RA
Grbs-122
On examination no pallor icterus cyanosis clubbing lymphadenopathy edema
CVS-S1 S2 heard
Rs-BAE present
P/A distended
CNS-NFND
Any investigations need to sent sir??
[22/08, 20:52] Dhu Edema 24: We should admit in ward sir ??
[22/08, 20:56]cm: Yes
Do they want special ward or general ward?
[22/08, 20:59]cm: Please share old investigations if any.
Investigations serum albumin, hemogram, chest X-ray, ECG, urine CUE
If serum albumin low and urine albumin+++, then urine for 24 hour protein and creatinine
[22/08, 21:00]cm: Serum creatinine
[22/08, 21:02] Dhu Edema 24: They want general ward sir
She was using dytor plus20/50mg
Famotidine 40mg
Ramipril 1.25mg
Pan d
[22/08, 21:02]cm: Since when?
[22/08, 21:03] PPM 1: Share the lateral view of her abdomen and arms
[22/08, 21:03] Dhu Edema 24: 7 years sir
[22/08, 21:04]cm: So she must have been investigated already! Share those
[23-08-2025 11:10] PPM 1: Reviewing in OPD:
Deaf mutism since birth
In Village school. Developed her own sign language between herself and mother.
Since 5 years of age recurrent fever and diarrhoea every month, lasted few days.
Admitted at the age of 12 years in special school 40 kms away and once she developed fever they again put her back to her village school. Also developed intermittent anasarca since then. Left the village school as well since 5 years although she has an urge to learn and go to school.
No pedal edema
Massive ascites
Fluid thrill present
Liver and spleen palpable on dipping method
Please get OBG opinion along with buccal smear for karyotyping
Carrying angle image attached
Get the LFT and creatinine report that was sent yesterday
[23-08-2025 11:20] PPM 1: @Meta AI @PPM4 @PPM5 what are the other investigations essential to investigate this 20 years old patient of deaf mutism and primary amenorrhea with decompensated cirrhosis of liver since 7 years with current massive ascites to find out etiology if possible?
[23-08-2025 11:20] Meta AI: Due to a high volume of conversations, our AIs may be slow to answer. Please try again later.
[23-08-2025 11:23] PPM 1: Ophthalmology slit lamp examination for KF ring
[23-08-2025 11:23] PPM 1: ENT for deafness
[23-08-2025 11:29] PPM 4: Of course. This is a profoundly complex and fascinating clinical case where a single underlying etiology is likely responsible for all the seemingly disparate symptoms. The combination of deaf-mutism, primary amenorrhea, and early-onset decompensated cirrhosis is a classic textbook presentation that points strongly towards specific metabolic and genetic disorders.
The investigative approach must be systematic, prioritizing both the management of the acute, life-threatening complication (decompensated cirrhosis with massive ascites) and the definitive search for the root cause.
Here are the essential investigations, categorized by their purpose:
I. Immediate & Essential Investigations for Cirrhosis and Ascites
These are critical for immediate management and to rule out common causes of liver disease, though they are unlikely to be the primary cause in this age group.
1. Ascitic Fluid Analysis (Diagnostic Paracentesis):
· Cell Count and Differential: To rule out Spontaneous Bacterial Peritonitis (SBP), a common and deadly complication.
· Albumin Level: To calculate the Serum-Ascites Albumin Gradient (SAAG). A SAAG ≥ 1.1 g/dL confirms portal hypertension, which is consistent with her cirrhosis.
· Culture and Sensitivity: (Bedside inoculation into blood culture bottles increases yield).
· Total Protein: Additional data point.
· Amylase: To rule out pancreatic cause.
2. Comprehensive Metabolic Panel:
· Liver Function Tests (LFTs): AST, ALT, ALP, GGT, Total Bilirubin (will be markedly elevated).
· Synthetic Function: Albumin, PT/INR (will be prolonged, indicating poor synthetic function).
· Renal Function: BUN, Creatinine, Electrolytes. Hepatorenal syndrome is a key concern.
3. Complete Blood Count (CBC): Look for anemia, leukopenia, and thrombocytopenia (signs of hypersplenism from portal hypertension).
4. Coagulation Profile (PT/INR): As above, crucial for assessing liver function and bleeding risk.
II. Investigations to Find the Primary Etiology (The Core of the Question)
This is where the unique combination of symptoms provides the crucial diagnostic clues.
A. Top Suspect: Wilson's Disease (Hepatolenticular Degeneration)
This is the most critical diagnosis to rule out immediately, as it is treatable. It is an autosomal recessive disorder of copper metabolism that can present with liver disease (cirrhosis) and neuropsychiatric symptoms (deafness can be a manifestation). Amenorrhea is also a common feature.
· Serum Ceruloplasmin: Will be low in ~85-90% of patients. (An acute-phase reactant, it can be normal in inflammation).
· 24-hour Urinary Copper Excretion: Markedly elevated (>100 mcg/24h is diagnostic).
· Slit-Lamp Examination: For Kayser-Fleischer (K-F) rings (copper deposition in the cornea). Presence is diagnostic in a patient with liver disease, but they may be absent in purely hepatic presentations.
· Serum Copper: Usually low (as ceruloplasmin, which carries copper, is low).
· Liver Copper Quantification: (If other tests are equivocal and a liver biopsy is performed). A value >250 mcg/g dry weight is diagnostic. This is the gold standard.
B. Other Metabolic & Genetic Causes of Cirrhosis and Systemic Symptoms
· Alpha-1 Antitrypsin Deficiency: Another treatable cause of early cirrhosis.
· Serum Alpha-1 Antitrypsin Level: Will be low.
· PiZZ Phenotyping: To confirm the homozygous abnormal genotype.
· Hemochromatosis: Though amenorrhea is a feature, deafness is not typical. Still, it's a common genetic cause of liver disease.
· Iron Studies: Serum Iron, Total Iron-Binding Capacity (TIBC), Ferritin. Transferrin Saturation >45% is a key early indicator.
· HFE Gene Mutation Analysis (C282Y, H63D).
· Autoimmune Hepatitis:
· Autoantibodies: ANA (Antinuclear Antibody), ASMA (Anti-Smooth Muscle Antibody), Anti-LKM1 (Liver-Kidney Microsomal type 1).
· Immunoglobulins: Elevated IgG is typical.
C. Investigations for Primary Amenorrhea and Deafness
The deaf-mutism suggests the issue is likely congenital/early childhood.
· Hormonal Panel for Amenorrhea:
· FSH, LH: To determine if the cause is hypergonadotropic (ovarian failure) or hypogonadotropic (central/hypothalamic-pituitary issue). In many metabolic disorders, it's hypergonadotropic.
· Estradiol: Will be low.
· Prolactin, TSH: To rule out other pituitary/thyroid causes.
· Pelvic Ultrasound: To visualize the uterus and ovaries. To confirm the presence of a uterus and assess ovarian size and morphology (e.g., streak ovaries in genetic syndromes).
· Karyotyping / Chromosomal Microarray: This is absolutely essential. To rule out:
· Turner Syndrome (45,X0): Associated with primary amenorrhea, short stature, and sometimes sensorineural hearing loss. Liver disease (NAFLD, autoimmune hepatitis) is a well-recognized, under-appreciated complication of Turner syndrome.
· Other chromosomal abnormalities.
III. Advanced/Definitive Investigations
· Abdominal Ultrasound with Doppler: Already likely done, but crucial to confirm cirrhotic morphology, assess spleen size, and patent blood flow (portal vein thrombosis is a common complication).
· Transient Elastography (FibroScan®): To quantify the degree of liver stiffness (fibrosis/cirrhosis), though ascites can interfere with the result.
· Upper Endoscopy: To screen for esophageal and gastric varices, which will dictate need for primary prophylaxis with beta-blockers.
· Liver Biopsy: May still be considered if the diagnosis remains elusive after the above workup. Histology can provide clues (e.g., copper deposition in Wilson's, iron in hemochromatosis, PAS-positive diastase-resistant globules in Alpha-1 Antitrypsin deficiency).
· Genetic Counseling and Next-Generation Sequencing Panels: If initial targeted testing is negative, a broad genetic panel for metabolic liver diseases, syndromic deafness, and disorders of sexual development would be the next step.
Summary and Recommended Diagnostic Pathway:
Step 1: Stabilize the Patient.
· Manage ascites (salt restriction, diuretics, therapeutic paracentesis).
· Rule out SBP with diagnostic paracentesis.
· Assess renal function and nutrition.
Step 2: Rule Out Wilson's Disease URGENTLY.
· This is the number one priority because it is treatable. Order serum ceruloplasmin, 24-hour urinary copper, and request an urgent ophthalmology consult for slit-lamp exam.
Step 3: Simultaneously Order:
· Karyotyping
· Alpha-1 Antitrypsin level and phenotype
· Iron studies (Ferritin, Transferrin Saturation)
· Hormonal workup (FSH, LH, Estradiol)
· Autoantibodies (ANA, ASMA)
Step 4: Based on Results:
· If Karyotype is 45,X0 → Turner Syndrome is the answer, explaining all three features.
· If Ceruloplasmin is low and Urinary copper is high → Wilson's Disease is the answer.
· If Alpha-1 Antitrypsin is low → Alpha-1 Antitrypsin Deficiency.
· If all above are negative, consider a liver biopsy and broader genetic testing.
This structured approach will efficiently narrow down the differential diagnosis and has a high chance of identifying the underlying cause in this young woman.
[23-08-2025 11:30] PPM 4: DeepSeek 👆
[23-08-2025 11:32] PPM 1: @PPM3 @PPM7 please find out from our lab if they are doing urinary copper
[23-08-2025 11:32] PPM 3: Okay sir
[23-08-2025 11:58] PPM 1: Now it appears @PPM6 is the actual incharge of the patient and not @PPM3! LFTe
What is the GGT?
Please get a DCT and Retic count.
There is albuminuria. Please get a spot urine protein creatinine ratio and a USG KUB to comment on the kidney size and corticomedullary differentiation.
[23-08-2025 12:20] PPM 8: Intermittent anasarca is unlikely with WD. Generally once decompensated, WD wouldn't recompensate without chelation, but ofcourse it should be ruled out
[23-08-2025 12:27] PPM 8: What is her INR?
[23-08-2025 12:39] PPM 1: I'll check the IVC hepatic vein axis again today in the afternoon @~Harika using our bedside device.
Will also record the echo texture etc on video
[23-08-2025 12:40] PPM 6: Okay sir
[23-08-2025 12:42] PPM 1: 👆@PPM6
[23-08-2025 12:43] PPM 6: I will send the sample now sir
[23-08-2025 12:44] PPM 1: Better send with the SAAG else she'll get two pricks
[23-08-2025 12:44] PPM 6: Okay sir
[23-08-2025 16:20] PPM 1: Did it during the afternoon session which turned out to be quite exciting and I nearly missed my bus.
Hepatic vein IVC axis was actually quite dilated and well visible unlike the other 70F patient with ascites and CKD lying beside her.
The portal vein was also normal size along with splenic.
We moved to the heart to do an echocardiography due to force of habit and that's when the clincher came.
We noticed the left atrium was unusually more dilated than the aortic root which was difficult to explain when @PPM9 pointed out the bright echoes on the pericardial surface and then I noticed that the left ventricular posterior wall wasn't moving freely and that's when the diagnosis hit us!
We quickly made her sit up to see her JVP and there it was!
[23-08-2025 16.49] PPM 1: https://youtube.com/shorts/TQ_nRUTGEn8?feature=shared
[23-08-2025 17:42] PPM 2: Eagerly waiting for the Echo video please.
[23-08-2025 18:50] PPM 8: This seems a great case for a bmj case report writeup once all investigations are in
[23-08-2025 18:56] PPM 10: Sir, for investigations of primary amenorrhea, perhaps we could start with a hormone profile followed by USG abdomen to confirm both endocrinological and anatomical normalcy?
I’ll try to look up any genetic syndromes that match these symptoms, perhaps there could be one that fits?
[23-08-2025 18:57] PPM 11: https://youtube.com/shorts/04snT86UU-w?feature=shared
I think this is the same case.
[23-08-2025 19:03] PPM 5: @PPM1 Sir
The clinical scenario with raised JVP, calcification of the pericardium, dilated left ventricle (LV) and left atrium (LA), but normal inferior vena cava (IVC) and hepatic veins, which mimics cirrhosis, strongly suggests constrictive pericarditis with associated left heart involvement.
Explanation:
Raised JVP and pericardial calcification point toward constrictive pericarditis, a condition where the pericardium becomes stiff and restricts heart filling.
Dilated LV and LA indicate volume overload or pressure changes affecting the left heart chambers. Constrictive pericarditis usually affects right-sided filling, but chronic pressure changes or coexisting cardiac pathology (like left ventricular dysfunction) can cause this dilatation.
Normal IVC and hepatic veins imply that the systemic venous congestion typical of constrictive pericarditis (which normally elevates pressures and alters flow in these veins) might be absent or compensated.
The presentation mimics cirrhosis because constrictive pericarditis can cause ascites and systemic venous congestion resembling liver disease, but the primary cause is cardiac.
Diagnosis: Constrictive pericarditis with left heart chamber dilatation mimicking cirrhosis.
This diagnosis explains ascites and raised JVP without actual liver pathology, emphasizing the importance of cardiac imaging (echo, CT, MRI) to distinguish it from hepatic causes.
If required, investigations like pericardial biopsy, hemodynamic catheterization, or advanced imaging can confirm constriction and guide treatment such as pericardiectomy.
[24-08-2025 08:34] PPM 1: The top priority right now is to get her simple chest X-ray and ECG which in our excitement yesterday we seem to have overlooked!
@PPM6 @PPM9 @PPM3
If our CT machine wasn't out of order we would have gotten a CT too as the pericardial calcification would have been better delineated there.
Previously the Mortality for pericardiectomy was pretty high but not sure what's the current evidence based deal with expensive video assisted thoracoscopic procedures. That's for your LLM to answer @PPM4and from your experience @Integrative Medicine Hyderabad
Perhaps this would be a great opportunity to set her up in a government medical college where her pericardiectomy can be attempted at no cost? @PPM5 Only problem is it's not going to be easy scraping off the pericardial fibrosis from her visceral pericardium and here's where the mortality probably increases. Anyways we'll need to start her on ATT.
Waiting eagerly to see if her chest X-ray too shows any active pulmonary tuberculosis other than the pericardial calcification @PPM12
[24-08-2025 09:07] PPM 8: I am wondering why is her albumin low? Only because of malnutrition? And why is she having proteinuria?
[24-08-2025 09:08] PPM 8: Are we thinking of Kochs as the primary etiology of pericarditis?
[24-08-2025 09:15] PPM 4: Of course. This is an excellent and critical pivot in the clinical reasoning. The discovery of pericardial calcification on imaging is a game-changer. It instantly shifts the primary diagnostic focus from the liver to the heart and re-frames the entire clinical picture.
Let's integrate this new, crucial finding.
Re-evaluating the Entire Case: The Unifying Diagnosis
The combination of decompensated cirrhosis (with ascites) and calcific constrictive pericarditis is not a coincidence. This is almost certainly a case of Cardiac Cirrhosis.
Pathophysiology:
1. Constrictive Pericarditis: The calcified, rigid pericardium prevents the heart from filling properly during diastole.
2. Elevated Central Venous Pressure (CVP): This impaired filling leads to a dramatic backup of pressure into the systemic venous system.
3. Hepatic Congestion: The high pressure is transmitted directly to the liver via the hepatic veins and inferior vena cava, causing chronic, passive congestion.
4. Cardiac Cirrhosis: Years of this congestion (7 years in this case) lead to hypoxia, centrilobular necrosis, bridging fibrosis, and ultimately, cirrhosis. The ascites in this scenario is both cardiac (due to high CVP) and hepatic (due to portal hypertension from cirrhosis).
The deaf-mutism and primary amenorrhea may still be separate, pre-existing conditions (e.g., congenital causes) or, less likely, could be part of a very rare syndromic presentation. However, the life-threatening issues now are the constrictive physiology and its sequelae.
---
Essential Investigations in Light of This New Finding
The investigative priorities now shift dramatically towards confirming and characterizing the constrictive physiology and managing its consequences.
1. Immediate Cardiac Investigations (Top Priority):
· Echocardiogram (TTE): This is the most critical next test. You will look for:
· Septal bounce: Abnormal motion of the interventricular septum due to interventricular dependence.
· Annulus Paradoxus: Mitral annular tissue velocity (e') is preserved on tissue Doppler imaging (TDI), which helps distinguish it from restrictive cardiomyopathy.
· Dilated Inferior Vena Cava (IVC) with less than 50% collapse during inspiration, indicating markedly elevated RA pressure.
· Diastolic equalization of pressures: Similar diastolic pressures in all four chambers.
· Cardiac MRI (if available): This is superior to CT for functional assessment. It can exquisitely detail:
· Pericardial thickness and calcification.
· Consequences of constriction: Septal bounce, IVC dilation, hepatic venous congestion.
· It can powerfully differentiate between constrictive pericarditis and restrictive cardiomyopathy.
· Right and Left Heart Catheterization (Gold Standard for diagnosis): This invasive test provides hemodynamic confirmation:
· Dip-and-plateau sign or square root sign in the ventricular pressure tracings.
· Elevated and equalized diastolic pressures across all chambers.
· Kussmaul's sign: Lack of drop or a rise in RA pressure with inspiration.
2. Investigations for Tuberculosis (The Likely Cause of Constriction):
Given the high prevalence in India, TB is the most common cause of calcific constrictive pericarditis.
· Sputum for AFB: (Smear and Cartridge-Based Nucleic Acid Amplification Test - CBNAAT, like GeneXpert) even in the absence of pulmonary symptoms.
· Ascitic Fluid Analysis: Send for ADA (Adenosine Deaminase), cell count, and PCR for TB. A high ADA in ascitic fluid can be suggestive of TB peritonitis, which can co-exist.
· Interferon-Gamma Release Assay (IGRA) or Tuberculin Skin Test: (Though these may be negative in chronic disease).
· Pericardial Tissue: If and when pericardiectomy is performed, the pericardial tissue must be sent for histopathology (looking for caseating granulomas) and culture/Molecular testing for M. tuberculosis.
3. Re-interpreting the Liver and Ascites:
The ascites is now understood to be of mixed cardiac and hepatic origin. The previous liver-focused workup (for Wilson's, etc.) becomes a lower priority but should still be completed to rule out a co-existing primary liver disease, though it is less likely.
---
Addressing Your Specific Questions
1. Pericardiectomy: Mortality and Modern Techniques
· Open Pericardiectomy remains the gold standard and the most common procedure, especially for dense, calcific constriction. It allows for complete decortication.
· Mortality: In experienced high-volume centers, operative mortality for elective pericardiectomy has improved significantly and is now in the range of 5-8%. It is higher (up to 20% or more) in advanced NYHA class (e.g., Class IV), renal dysfunction, or poor LV function.
· VATS (Video-Assisted Thoracoscopic Surgery): While excellent for pericardial drainage/window or partial pericardiectomy for effusions, it is not suitable for dense, calcific, chronic constrictive pericarditis. The procedure requires meticulous, careful peeling of the pericardium off the heart surface, which demands the tactile feedback and control of an open procedure to avoid catastrophic hemorrhage from tearing the heart or coronary arteries.
2. Government Medical College Referral This is anexcellent plan. This is a high-risk, complex surgery that requires a multidisciplinary team (cardiothoracic surgeons, cardiologists, intensivists) and a well-resourced ICU. A large government medical college is often the best-equipped place to handle such cases, especially with the goal of providing care at no cost.
3. Starting ATT (Anti-Tubercular Therapy) Absolutely correct.If TB is suspected (which it strongly is), starting ATT is mandatory. The standard 4-drug regimen (HRZE) should be initiated. Often, patients are started on ATT pre-operatively and must continue it for a full course (e.g., 9-12 months) post-operatively. This treats the underlying infection and can prevent recurrence.
Conclusion and Final Recommendations:
1. Immediate Focus: Shift from a "liver failure" mindset to a "heart failure with secondary cardiac cirrhosis" mindset.
2. Diagnostic Triad: Get the Echocardiogram and Cardiac MRI urgently. These will confirm the constrictive physiology.
3. Start Empirical ATT: Given the high clinical suspicion for TB pericarditis.
4. Refer: Expedite referral to a cardiothoracic surgery center at a government medical college for evaluation for open pericardiectomy.
5. Manage Symptoms: Continue careful management of ascites and diuresis, understanding that the definitive treatment is surgical relief of the constriction.
This is a challenging but potentially treatable condition. The cirrhosis and ascites may even see significant improvement after a successful pericardiectomy relieves the chronic backward pressure on the liver. [DeepSeek]
[24-08-2025 09:15] PPM 2: Frankly I see it much better on the left side with prominent x and y collapse
I still think hepatic vein pulse wave dopplwr is the clincher for a CP (from the tools we have, rather than a CT or calcification on echo)
Simply point the PW dopplwr at the hepatic vein and check for flow reversal into IVC. If it happens in systole it is tricuspid regurg and if it happens in diastole, then constrictive vs restrictive cardiomyopathy can be considered.
To nitpick further, if the flow reversal worsens with inspiration in diastole, then it is nailed on Constrictive Pericarditis and if it worsens with expiration, it is diagnostic of restrictive cardiomyopathy
[24-08-2025 11:02] PPM 1: How much is her proteinuria? I didn't notice that although I found @PPM8 also mention it earlier
@PPM6 any urine report
[24-08-2025 11:04] PPM 1: Should be easy to do. What you are suggesting is establish the physiological diagnosis and looking at calcification would be anatomical pathological diagnosis
ECG
Chest X-ray
[24-08-2025 11:07] PPM 1: RVH @PPM9?
[24-08-2025 13:10] PPM 8: Yes it is normal. I misread the report.
[25-08-2025 12:29] PPM 1: Ascitic fluid SAAG? @PPM6@PPM9@PPM3
TLC DLC?
[25-08-2025 12:30] PPM 1: Chest X-ray lateral view?
[25-08-2025 12.36] PPM 1: 20F already discussed on Saturday with better JVP captured today
[25-08-2025 12:40] PPM 1: We asked for ascitic TLC DLC! Hemogram was already shared![25-08-2025 12:47] PPM 6: We are waiting for the report sir
[25-08-2025 15.23] PPM 6: Saag: 1.6 gm /dl
[25-08-2025 16:29] PPM 1: Sputum AFB? Get a pulmonology opinion for starting empirical antitubercular therapy
[25-08-2025 16:29] PPM 6: Okay sir
[25-08-2025 16:30] PPM 9: Tuberculosis causing constructive pericarditis? sir
[25-08-2025 17:42] PPM 1: Yes
[25-08-2025 17:42] PPM 1: First hypothesis
[25-08-2025 18:07] PPM8: It's a high SAAG ascites. Do the ascitic fluid protein match the expectations of cardiac ascites?
[25-08-2025 19:28] PPM 1: @PPM6 what's the ascitic fluid protein?
[25-08-2025 19:33] PPM 6: 1gm/dl sir
[26-08-2025 08:29] PPM 1: That looks like low protein ascites @~Tamoghna
But logically if a patient has cardiac cirrhosis due to constrictive pericarditis that began 7 years back wouldn't the liver synthetic function also take a setback and mimic ascitic protein findings expected in those that have high SAAG low protein predominantly due to liver synthetic failure such as usual cirrhosis of liver?
[26-08-2025 08:33] PPM 1: Let's hope to see her sputum AFB and trunat today and a chest and TB note in her file shared here
[26-08-2025 08:50] PPM 8: Her synthetic function is not that deranged. INR is normal.
[26-08-2025 08:50] PPM 8: The hypoalbuminemia may be due to malnutrition per se
[26-08-2025 08:58] PPM 6: Okay sir
[26-08-2025 09:40] PPM 1: Good point!
This insight can get into our hypoalbuminemia ProJR archive here: https://pajrcasereporter.blogspot.com/2025/06/hypoalbuminemia-projr.html?m=1
[26-08-2025 16:22] PPM 6: Ascitic fluid culture and sensitivity and zn stain report
[26-08-2025 16:25] PPM 1: Ascitic fluid we didn't expect much.
Only by chance if there's any AFB in her lung (sputum) or even from sputum trunat.
Either way let's prepare her discharge on antitubercular therapy with a letter for her DOTs centre from our rntep centre downstairs
Here is a cleaned-up, interpreted, and structured version of the ENT referral note.
---
### *Interpreted ENT Referral Note*
*To:* ENT Department / Specialist
*From:* [Referring Doctor's Name - Not Legible]
*Re:* Consultation Request for a patient with hearing and speech difficulties.
*Patient History:*
* The patient is a known case of *β-Thalassemia Major* under the care of the Thalassemia Unit.
* The patient has had *bilateral sensorineural hearing loss* since childhood and is *non-verbal* (cannot speak), but can make some sounds.
* The patient has been using a *hearing aid since the age of 5* (usage is reported as "on and off").
* The patient indicates that hearing is better in the *right ear (R) with the hearing aid*.
* *No other ear, nose, or throat complaints* reported (e.g., no discharge, pain, tinnitus, vertigo).
* History of a *normal, full-term delivery* (no complications noted at birth).
* *No history of TORCH infections* (a key cause of congenital hearing loss).
* The patient's *body was discolored (jaundiced) immediately after birth*.
* *No history of blood transfusion* (this is unusual for Thalassemia Major and may be a error in the note or history).
*Findings on Physical Examination (POE):*
* *General:* Patient is conscious, coherent, cooperative. Well-nourished and can perform day-to-day activities independently.
* *Vitals:* Blood Pressure: 100/? mmHg, Pulse Rate: 74 bpm (normal).
* *Ears (as described):*
* *Pinna:* Normal appearance.
* *Canals:* Patent (open).
* *Tympanic Membranes:* Normal.
* *Post-auricular region:* No tenderness or abnormalities.
*Impression:*
1. *Bilateral Profound Sensorineural Hearing Loss* (since childhood, etiology undetermined).
2. Status post hearing aid use (with suboptimal compliance).
3. Known case of *Beta-Thalassemia Major*.
*Reason for Referral / Requested Action:*
* *Formal Audiological Assessment:* To objectively evaluate the current degree and type of hearing loss and to assess the benefit from the existing hearing aid.
* *Hearing Aid Rehabilitation:* To optimize hearing aid fitting and ensure consistent use to support communication.
* *Assessment for Alternative Options:* To evaluate if the patient is a candidate for other interventions, such as *cochlear implantation*, given the early onset of deafness leading to mutism.
* *Rule out any other ENT pathology.*
---
*Note on Interpretation:* The line "Gzekleri - T. Ketler T High SAA6" was interpreted as "β-Thalassemia Major" based on context ("Thalassemia Unit") and common medical terminology. "Hannah/Honu delivery" was interpreted as "Normal delivery." "Body distort" was interpreted as "body discolored," suggesting neonatal jaundice, a common finding in hemolytic conditions like thalassemia.
This note should be followed by a comprehensive ENT examination and audiological testing.
[27-08-2025 13:50] PPM 1: She has HbE Thalasemia trait
[27-08-2025 13:52] PPM 1: How is the tuning fork test being done in this patient of congenital deafness? @PPM4
[27-08-2025 14:05] PPM 4: Of course. This note documents a detailed otological examination, including tuning fork tests, for the patient with congenital deafness.
The handwriting is highly abbreviated and contains errors, but the key findings can be interpreted. Here is a breakdown of how the tuning fork tests are being performed and what the results mean.
### Interpretation of the Tuning Fork Tests
The examiner is using two primary tests: the *Rinne test* and the *Weber test. They are using tuning forks of at least three different frequencies: **512 Hz* (the standard), *256 Hz, and **1024 Hz*. Using multiple frequencies is a good practice to confirm findings.
---
#### 1. Weber Test (Test for Lateralization)
* *How it's done:* The base of a vibrating tuning fork (likely 512 Hz) is placed on the midline of the patient's forehead or on the bridge of the nose.
* *What the patient is asked:* The patient (who is non-verbal) is asked to sign or indicate where they hear the sound best: in the center, in the right ear, or in the left ear.
* *Result in this patient:* The note states, *"Patient is signing as AC is lancement with 85, 512 and 1024 Hz"*.
* *Interpretation:* This likely means the patient indicates (via signing) that the sound is heard in the *center ( midline)* for all frequencies (256, 512, 1024 Hz). The word "lancement" is probably a misspelling of "midline" or "central".
* *What this means:* A *midline Weber* suggests one of two things:
1. *Normal hearing* in both ears.
2. *Equal, symmetric sensorineural hearing loss (SNHL)* in both ears.
* Given the patient's known history of *bilateral congenital deafness, this result strongly points to **symmetric bilateral sensorineural hearing loss*. This is a classic finding.
#### 2. Rinne Test (Compare Air vs. Bone Conduction)
* *How it's done:* The vibrating tuning fork is first placed on the mastoid bone behind the ear (testing *Bone Conduction, BC). When the patient can no longer hear it, the fork is immediately moved next to the ear canal (testing **Air Conduction, AC*). The patient is asked to signal which position is louder.
* *What a normal result is:* Air Conduction is louder than Bone Conduction (Rinne *Positive*).
* *What an abnormal result is:* Bone Conduction is louder than Air Conduction (Rinne *Negative*), suggesting a conductive hearing loss in that ear.
* *Result in this patient:* The note is messy but under "CAL" (likely meaning the *Left Ear), it states parameters that seem to describe the tympanic membrane (Tm), not the test result. However, the critical line is: **"Witness deteasised to D DC - normal normal"*
* *Interpretation:* This is likely a very garbled way of writing "*Rinne test is negative on both sides, DC > AC*". "DC" might be a miswriting for "BC" (Bone Conduction).
* *What this means:* A *negative Rinne (BC > AC)* on both sides would typically indicate a *bilateral conductive hearing loss. However, this **contradicts* the patient's known history of sensorineural loss and the Weber test result.
This creates a clinical contradiction. The most likely explanations are:
1. *Misinterpretation by a non-verbal patient:* The test is subjective and relies on patient feedback. A patient who has been deaf since childhood may not be able to reliably indicate which is louder, leading to an invalid result.
2. *Error in note-taking/abbreviation:* The phrase "negative fructose" is nonsense and suggests the writer was hurried or made errors. The "Rinne test" result is likely recorded incorrectly.
### Summary of Tuning Fork Findings & Clinical Conclusion
| Test | How It Was Done | Result | Interpretation |
| :--- | :--- | :--- | :--- |
| *Weber* | Tuning fork on forehead. Patient signed response. | *Midline (Central)* for 256, 512, 1024 Hz. | *Symmetric hearing loss.* Consistent with *bilateral sensorineural hearing loss*. |
| *Rinne* | Comparing air vs. bone conduction. | Note is unclear but suggests Negative bilaterally. | This would indicate a conductive loss, which is *inconsistent* with history and Weber. Likely an *invalid result* due to patient communication barriers. |
*Final Answer to Your Question:*
The tuning fork tests are being performed in the standard manner:
1. *Weber Test:* Placed on the forehead; the patient uses sign language to indicate where the sound is loudest.
2. *Rinne Test:* Done by alternating the fork between the mastoid bone and the ear canal; the patient signals when they can no longer hear it.
However, the *results are likely unreliable. The patient's congenital deafness and inability to speak make it very difficult to obtain valid subjective responses for the Rinne test. The **Weber test result (midline)* is the most trustworthy finding and is classic for their known condition of *bilateral sensorineural hearing loss*.
*Next Step:* The objective tests mentioned elsewhere in the note (*Pure Tone Audiometry*) are absolutely essential for this patient to get an accurate, measurable assessment of their hearing loss, as subjective tuning fork tests are of limited value.
[27-08-2025 14:10] PPM 1: AI appears to be attributing as the doctor's writing error, it's own inability to read the doctor's handwriting?
[27-08-2025 14:26] PPM 4: But I totally agree with this DeepSeek interpretation of the examining doctor's handwritten notes and the AI's conclusions
Gyn opinion
Gyn opinion
Chest and TB review to start ATT for clinical constrictive pericarditis?
[28-08-2025 14:25] PPM 1: Thanks. So their next plan is HRCT chest.
[28-08-2025 14:25] PPM 6: Yes sir
[28-08-2025 14:34] PPM 1: Will they be able to afford it?
Also not sure how much more that may help other than picking up calcification.
Ask them to meet in AMC
[28-08-2025 14:38] PPM 6: Okay sir
[29-08-2025 08:42] PPM 1: DIAGNOSIS
CHRONIC CONSTRICTIVE PERICARDITIS
CIRRHOSIS WITH ASCITES
GENERALISED ANASARCA
THALASEMMIA TRAIT+
HBE+
HISTORY
PATIENT COMPLAINTS OF ABDOMINAL DISTENSION SINCE 7 YRS. COMPLAINTS OF FACIAL SWELLING AND PEDAL EDEMA SINCE 7 YEARS ON AND OFF RELIEVED BY MEDICATION
HOPI: PT WAS APPARENTLY ASYPTOMATIC 7YEARS AGO NOW CAME WITH THE C/O ABDOMINAL DISTENSION SINCE 7YEARS WHICH IS INSIDIOUS IN ONSET GRADUALLY PROGRESSIVE PT C/O FACIAL SWELLING AND PEDAL EDEMA SINCE 7YRS ON AND OFF RELIEVED BY MEDICATION
PT HAD A H/O NFEVER ON AND OFF RELIEVED BY MEDICATION SINCE CHILDHOOD SHE IS UNABLE TO HEAR AND TALK.NO H/O CHEST PAIN, SOB, ORTHOPNOEA, PND, SWEATING, PALPITATIONS
NO H/O VOMITINGS LOOSE STOOLS, COLD, COUGH, HEADACHE
NO H/O LOC, GIDDINESS, WEAKNESS OF UL AND LL
PAST HISTORY: N/K/C/O T2DM, HTN, ASTHMA, COPD, EPILEPSY, CAD, CVA, THYROID DISORDER
PERSONAL HISTORY
PATIENT IS MARRIED, NORMAL APPETITE, MIXED DIET, REGULAR BOWEL MOVEMENTS ,NORMAL MICTURITION, NO KNOWN ALLERGIES
GENERAL EXAMINATION
PATIENT IS C/C/C.
NO PALLOR, NO ICTERUS, CYANOSIS, CLUBBING, LYMPHADENOPATHY, PEDAL EDEMA,
MALNUTRITION, DEHYDRATION.
TEMPERATURE - 98.4F
PR - 102BEATS/MIN
BP- 110/60 MM HG
RR - 18CPM
SPO2 - 97%AT RA
GRBS:122MG/DL
SYSTEMIC EXAMINATION
CVS- S1 S2 HEARD, NO MURMURS
RS- BAE PRESENT, NVBS HEARD
PER ABDOMEN - DISTENDED
CNS EXAMINATION
1. NO SPEECH
2. PUPIL SIZE RT- N LT- MID DILATED
3. HIGHER MENTAL FUNCTIONS
PT IS CONSCIOUS , ORIENTED TO PERSON
TONE UL N N
LL N N
POWER UL 5/5 5/5
LL 5/5 5/5
REFLEXES
BICEPS +2 +2
TRICEPS +2 +2
SUPINATOR +1 +1
KNEE +2 +2
ANKLE +1 +1
PLANTAR FLEXOR FLEXOR
OPHTHALMOLOGY REFERAL WAS DONE ON 23/8/25 I/V/O KF RING ON SLIT LAMP EXAMINATION NORMAL NO KF RINGS SEEN AND ADVISED TO CONTINUE SAME TREATMENT AS PHYSICIAN
ENT REFERAL WAS DONE ON 27/08/2025 I/V/O DEAFNESS AND WAS ADVISED SPEECH THERAPY AND ADVISED TO CONTINUE SAME TREATMENT AS PHYSICIAN
PULMONOLOGY REFERRAL WAS DONE ON 27/08/25 I/V/O SUSPECTED TB & WAS ADVISED MONTOUX TEST, INDUCE SPUTUM FOR C/S, AFB IF NEGATIVE PLAN FOR BRONCHOSCOPY, HRCT CHEST AND WAS ADVISED TO CONTINUE SAME TREATMENT AS PHYSICIAN
OBGYN REFERRAL WAS DONE ON 27/8/25 AND WAS ADVISED UPT, CBP, CUE, USG ABDOMEN AND PELVIS, TFT, S. PROLACTIN, RBS AND TO CONTINUE SAME TREATMENT AS ADVISED
INVESTIGATIONS
HEMOGRAM DONE ON 22/8/2025
HB:11.5 TLC:6.62 RBC COUNT:4.8 PCV:33.2 PLT:102
HEMOGRAM DONE ON 24/8/2025
HB:10.8 TLC:5700 RBC COUNT:4.5 PCV:31.4 PLT:100
CUE
COLOR: PALE YELLOW
APPEARANCE: CLEAR
ALBUMIN: 30MG/DL
PUS CELLS :2-3
EPITHELIAL CELS:2-3
RBC: NIL
CRYSTALS: NIL
CASTS: NIL
AMORPHOUS DEPOSITS: NIL
RFT DONE ON 24/8/25
UREA 22
CREATININE 0.6
URIC ACID 3.1
CALCIUM 8.7
PHOSPHOROUS 2.8
SODIUM 136
POTASSIUM 3.5
CHLORINE 99
LFT DONE ON 24/8/2025
T.BILIRUBIN 0.72
D.BILIRUBIN 0.18
SGOT 22
SGPT 27
ALP 286
TOTAL PROTEINS 4.4
ALBUMIN 2.2
GLOBULIN 2.2
A/G RATIO 1
ASCITIC FLUID SUGAR 96
ASCITIC FLUID PROTEIN 1.0
ASCITIC FLUID ALBUMIN 0.6
ASCITIC FLUID LDH 63
ASCITIC FLUID CULTURE: NO BACTERIAL GROWTH SEEN
CBNAAT NEGATIVE
CYTOLOGY ON 25/8/25 REPORT:NO EVIDENCE OF ATYPICAL CELLS IN THE SMEAR STUDIED
USG DONE ON 28/8/25
IMPRESSION: GROSS ASCITES
A/S/O CHRONIC LIVER DISEASE
-HYPOPLASTIC UTERUS AND SMALL OVARIES
TREATMENT
FLUID RESTRICTION<1.5L/DAY
SALT RESTRICTION <2GM/DAY
T.PAN-D 20MG/10MG PO/OD
TAB ALDACTONE 50MG PO/OD
TABLASIX 40MG PO/OD
TAB MVT PO/OD
MONITOR VITALS AND INFORM SOS
ADVICE AT DISCHARGE
FLUID RESTRICTION<1.5L/DAY
SALT RESTRICTION <2GM/DAY
T.PAN-D 20MG/10MG PO/OD
TAB ALDACTONE 50MG PO/OD
TABLASIX 40MG PO/OD
TAB MVT PO/OD
[29-08-2025 08:42] PPM 1: Add antitubercular therapy from dots to her advice at discharge mentioning:
Started empirical antitubercular therapy to address likely etiology of chronic constrictive pericarditis from ntep program to be taken from her local PHC under DOTs
Modify diagnosis as mentioned below:
Final diagnosis modified:
DIAGNOSIS
CHRONIC CONSTRICTIVE PERICARDITIS 7 years
Cardiac CIRRHOSIS WITH ASCITES
GENERALISED ANASARCA
HbE THALASEMMIA TRAIT+
Primary Amenorrhea
HISTORY
PATIENT COMPLAINTS OF ABDOMINAL DISTENSION SINCE 7 YRS with intermittent fever episodes that necessitated removal from her special school for the deaf and dumb.
COMPLAINTS OF FACIAL SWELLING AND PEDAL EDEMA SINCE 7 YEARS ON AND OFF RELIEVED BY MEDICATION
PT WAS born with congenital deafness and mutism and was otherwise APPARENTLY Asymptomatic 7 YEARS AGO NOW CAME WITH THE C/O ABDOMINAL DISTENSION SINCE 7 YEARS WHICH IS INSIDIOUS IN ONSET GRADUALLY PROGRESSIVE PT C/O FACIAL SWELLING AND PEDAL EDEMA SINCE 7 YRS ON AND OFF RELIEVED BY MEDICATION
PT HAD A H/O FEVER ON AND OFF RELIEVED BY MEDICATION
SINCE CHILDHOOD SHE IS UNABLE TO HEAR AND TALK.
NO H/O CHEST PAIN, SOB, ORTHOPNOEA, PND, SWEATING, PALPITATIONS
NO H/O VOMITINGS LOOSE STOOLS, COLD, COUGH, HEADACHE
NO H/O LOC, GIDDINESS, WEAKNESS OF UL AND LL
PAST HISTORY: N/K/C/O T2DM, HTN, ASTHMA, COPD, EPILEPSY, CAD, CVA, THYROID DISORDER
PERSONAL HISTORY:
NORMAL APPETITE, MIXED DIET, REGULAR BOWEL MOVEMENTS, NORMAL MICTURITION, NO KNOWN ALLERGIES
GENERAL EXAMINATION
PATIENT IS C/C/C.
NO PALLOR, NO ICTERUS, CYANOSIS, CLUBBING, LYMPHADENOPATHY, PEDAL EDEMA,
MALNUTRITION, DEHYDRATION.
TEMPERATURE - 98.4F
PR - 102BEATS/MIN
BP- 110/60 MM HG
RR - 18CPM
SPO2 - 97%AT RA
GRBS:122MG/DL
JVP: Raised with prominent Vy collapse
SYSTEMIC EXAMINATION
CVS- S1 S2 HEARD, NO MURMURS
RS- BAE PRESENT, NVBS HEARD
PER ABDOMEN - Moderate Ascites
CNS EXAMINATION
1. NO SPEECH
2. PUPIL SIZE RT- N LT- MID DILATED
3. HIGHER MENTAL FUNCTIONS
PT IS CONSCIOUS, ORIENTED TO PERSON
TONE UL N N
LL N N
POWER UL 5/5 5/5
LL 5/5 5/5
REFLEXES
BICEPS +2 +2
TRICEPS +2 +2
SUPINATOR +1 +1
KNEE +2 +2
ANKLE +1 +1
PLANTAR FLEXOR FLEXOR
OPHTHALMOLOGY REFERAL WAS DONE ON 23/8/25 I/V/O KF RING ON SLIT LAMP EXAMINATION NORMAL NO KF RINGS SEEN AND ADVISED TO CONTINUE SAME TREATMENT AS PHYSICIAN
ENT REFERAL WAS DONE ON 27/08/2025 I/V/O DEAFNESS AND WAS ADVISED SPEECH THERAPY AND ADVISED TO CONTINUE SAME TREATMENT AS PHYSICIAN
PULMONOLOGY REFERRAL WAS DONE ON 27/08/25 I/V/O SUSPECTED TB & WAS ADVISED MONTOUX TEST, INDUCE SPUTUM FOR C/S, AFB IF NEGATIVE PLAN FOR BRONCHOSCOPY, HRCT CHEST AND WAS ADVISED TO CONTINUE SAME TREATMENT AS PHYSICIAN
OBGYN REFERRAL WAS DONE ON 27/8/25 for primary amenorrhea AND WAS ADVISED UPT, CBP, CUE, USG ABDOMEN AND PELVIS, TFT, S. PROLACTIN, RBS AND TO CONTINUE SAME TREATMENT AS ADVISED
INVESTIGATIONS
HEMOGRAM DONE ON 22/8/2025
HB:11.5 TLC:6.62 RBC COUNT:4.8 PCV:33.2 PLT:102
HEMOGRAM DONE ON 24/8/2025
HB:10.8 TLC:5700 RBC COUNT:4.5 PCV:31.4 PLT:100
CUE
COLOR: PALE YELLOW
APPEARANCE: CLEAR
ALBUMIN:30MG/DL
PUS CELLS :2-3
EPITHELIAL CELS:2-3
RBC: NIL
CRYSTALS: NIL
CASTS: NIL
AMORPHOUS DEPOSITS: NIL
RFT DONE ON 24/8/25
UREA 22
CREATININE 0.6
URIC ACID 3.1
CALCIUM 8.7
PHOSPHOROUS 2.8
SODIUM 136
POTASSIUM 3.5
CHLORINE 99
LFT DONE ON 24/8/2025
T.BILIRUBIN 0.72
D.BILIRUBIN 0.18
SGOT 22
SGPT 27
ALP 286
TOTAL PROTEINS 4.4
ALBUMIN 2.2
GLOBULIN 2.2
A/G RATIO 1
ASCITIC FLUID SUGAR 96
ASCITIC FLUID PROTEIN 1.0ASCITIC FLUID ALBUMIN 0.6
ASCITIC FLUID LDH 63
ASCITIC FLUID CULTURE: NO BACTERIAL GROWTH SEEN
CBNAAT NEGATIVE
CYTOLOGY ON 25/8/25 REPORT:NO EVIDENCE OF ATYPICAL CELLS IN THE SMEAR STUDIED
USG DONE ON 28/8/25
IMPRESSION: GROSS ASCITES
A/S/O CHRONIC LIVER DISEASE
-HYPOPLASTIC UTERUS AND SMALL OVARIES
TREATMENT
Started empirical antitubercular therapy to address likely etiology of chronic constrictive pericarditis from ntep program to be taken from her local PHC under DOTs
FLUID RESTRICTION<1.5L/DAY
SALT RESTRICTION <2GM/DAY
T.PAN-D 20MG/10MG PO/OD
TAB ALDACTONE 50MG PO/OD
TABLASIX 40MG PO/OD
TAB MVT PO/OD
MONITOR VITALS AND INFORM SOS
ADVICE AT DISCHARGE
FLUID RESTRICTION<1.5L/DAY
SALT RESTRICTION <2GM/DAY
T.PAN-D 20MG/10MG PO/OD
TAB ALDACTONE 50MG PO/OD
TABLASIX 40MG PO/OD
TAB MVT PO/OD
[29-08-2025 08:56] PA: Sir aaj chuti kariye din sir
[29-08-2025 09.15] PPM 1: Hain upore ore discharge ta lekha
[02-09-2025 19.27] PA: Sir bari ashar par fulata aktu barche, Laxik tableta dui time karbo naki sir
[02-09-2025 20:07] PPM 1: Hain
8:00 AM
12:00 PM
[02-09-2025 20:07] PPM 1: TB 'r oshudh cholche?
[03-09-2025 10:33] PPM 8: This patient can be written up by any of the current students managing her. Along with the Echo and clinical examination video, it would be appreciated by any leading journal (in clinical images/videos section, maybe NEJM). Constrictive pericarditis due to TB causing massive ascites is a rare diagnosis in the western world. They hardly get any such case.
[04-09-2025 09:21] PPM 5: @PPM1 Sir we didn't get confirmation of diagnosis of TB... I think Truenat was negative.
[04-09-2025 09:41] PPM 1: Exactly writing the case is even more important in terms of how one is forced to treat tuberculosis empirically due to diagnostic and therapeutic uncertainty in low resource settings.
Check out a few similar past write ups from our volunteers here:
As a second step, please check out our clinical complexity case reports around Tuberculosis by entering tuberculosis in the search engine of this current PaJR patient archive here:
Also this dashboard with links to 5000 cases where one may be able to extract the ones with tuberculosis and it's empirical clinical complexity 👇
[04-09-2025 09:48] PPM 5: can we check with Mantoux test in this patient sir?
[04-09-2025 09:50] PPM 1: Yes. @PPM9 did we miss getting it done while she was admitted?
But what if it's positive? That wouldn't confirm anything other than prior exposure and immunity. It can be positive in many normal people around you
[04-09-2025 09:51] PPM 1: @PA unader bolun ekbar okhan theke chamrar mantoux test ta koriye nite
[04-09-2025 09:52] PPM 1: If it's negative it cannot rule out TB as anergy is not uncommon. @Meta AI what is anergy and what are the causes of false negative and false positive mantoux test?
[04-09-2025 09:52] Meta AI: Anergy refers to the lack of an immune response to a test antigen, even when the immune system is otherwise functional. In the context of the Mantoux test (a tuberculin skin test for tuberculosis), anergy can occur if the immune system is suppressed and unable to mount a response to the injected tuberculin.
### Causes of False-Negative Mantoux Tests:
1. Anergy (Immune Suppression): Conditions like HIV/AIDS, malnutrition, or immunosuppressive therapy (e.g., corticosteroids, chemotherapy) can suppress immune response.
2. Recent TB Infection: It can take up to 8 weeks after TB exposure for the body to develop a detectable immune response.
3. Very Young or Very Old Age: Infants and elderly individuals may not produce a strong enough reaction.
4. Improper Administration or Reading of the Test: Incorrect injection technique or poor interpretation of the induration can lead to errors.
5. Overwhelming TB Disease: In severe cases of active TB, the immune system may be too overwhelmed to respond.
### Causes of False-Positive Mantoux Tests:
1. Previous BCG Vaccination: The Bacillus Calmette-Guérin (BCG) vaccine can cause a positive reaction, as it contains a strain of live attenuated Mycobacterium bovis.
2. Infection with Non-Tuberculous Mycobacteria: Exposure to environmental mycobacteria can cause cross-reactivity.
3. Improper Administration or Reading of the Test: Errors in technique or interpretation can again be an issue.
Would you like to explore how the Mantoux test is compared with other TB diagnostic methods?
[04-09-2025 09:54] PPM 8: Mantoux is of not much importance in a 20 year old in a high endemicity country
[04-09-2025 09:55] PPM 8: Plz check the NTEP 2025 guidelines on screening. They have probably classified into high and low endemicity regions. In low endemicity regions, mantoux may still be important. In high endemicity, IGRA was recommended. But I may be wrong. Needs to be rechecked.
[04-09-2025 09:57] PPM 5: If possible they can get a microscopy done sir.. chances are some ntep centers might have a protocol to confirm the diagnosis.
[04-09-2025 09:59] PPM 8: It's very hard to confirm a diagnosis in EP TB. CBNAAT from ascitic fluid is frequently negative, as in this case. The only possibility was if we could get an accessible lymph node for FNA
[04-09-2025 10:01] PPM 9: We didn't do it sir
[04-09-2025 10:07] PPM 5: https://tbcindia.mohfw.gov.in/wp-content/uploads/2023/05/7702334778Training_Module_on_Extrapulmonary_TB_-_Book_24032023.pdf
[04-09-2025 10:09] PPM 8: Yes. I don't remember whether prednisolone was given to this patient?
[04-09-2025 10:18] PPM 5: ADVICE AT DISCHARGE
FLUID RESTRICTION<1.5L/DAY
SALT RESTRICTION <2GM/DAY
T.PAN-D 20MG/10MG PO/OD
TAB ALDACTONE 50MG PO/OD
TABLASIX 40MG PO/OD
TAB MVT PO/OD
[04-09-2025 10:18] PPM 5: This document is from 2023
[04-09-2025 10:18] PPM 5: Couldn't find a latest release
[04-09-2025 10:19] PPM 8: Plz check the guidelines for screening in asymptomatic individuals.
[04-09-2025 10:20] PPM 8: It must be there in NTEP website
[04-09-2025 12.02] PPM 5: diagnosis algorithm
[04-09-2025 12:03] PPM 5: Couldn't find any specific information about asymptomatic tb diagnosis
[04-09-2025 12:03] PPM 5: I think other risk group algorithm can be used instead
[04-09-2025 15:41] PPM 1: Microscopy of what sample?
[04-09-2025 15:41] PPM 5: FNAC of lymphnode?..
[04-09-2025 15:42] PPM 5: I'm not familiar with it sir.. but what would be the protocol in this case?
[04-09-2025 15:42] PPM 1: She didn't have lymph nodes in the clinical examination findings did she?
[04-09-2025 15:43] PPM 5: anything suggestive of tb in this CXR?
[04-09-2025 15:43] PPM 1: In pericardial TB? Only pericardial tissue biopsy
[04-09-2025 15:43] PPM 1: Nothing.
Sputum AFB and CBNAAT are also negative as expected
[04-09-2025 15:44] PPM 5: if we need to confirm there is no way other than biopsy?
[04-09-2025 15:44] PPM 1: Yes her problems started 7 years back but we could try steroids. Let's see how the antituberculars do
[04-09-2025 15:44] PPM 5: maybe mantoux test can help in ruling out tb if its negative..?
[04-09-2025 15:45] PPM 1: Pathology is the mother of medicine and Pathos it's father
[04-09-2025 15:45] PPM 1: Already answered above as to why it won't. Anergy
[04-09-2025 15:46] PPM 5: Yep
[04-09-2025 15:48] PPM 5: And yes.. did we rule out all other causes?
[04-09-2025 15:49] PPM 5: @Meta AI help us in differential diagnosis of this case https://pajrcasereporter.blogspot.com/2025/08/20f-cirrhosis-ascites-with-anasarca-7.html in ruling out all the causes of pericarditis to consider if its caused by tb.
give a list of differentials to consider in this case. scan images and all the data mention in the website
[04-09-2025 15:49] Meta AI: Let's break down the case and differential diagnosis.
The patient is a 20-year-old female with:
1. Abdominal distension and ascites since 7 years
2. Facial swelling and pedal edema (on and off)
3. Deaf-mutism since birth
4. Primary amenorrhea
5. Recurrent fever and diarrhea
6. Decompensated cirrhosis with massive ascites
Given the complexity of the case, let's consider the differentials for the underlying causes:
### Hepatic Causes
- Wilson's Disease: Given the cirrhosis, neuropsychiatric symptoms (deafness), and amenorrhea, this is a strong contender. Investigations: Serum ceruloplasmin, 24-hour urinary copper, slit-lamp examination for Kayser-Fleischer rings.
- Autoimmune Hepatitis: Could present with cirrhosis and extrahepatic manifestations. Investigations: ANA, anti-LKM antibodies, serum immunoglobulins.
- Non-Alcoholic Fatty Liver Disease (NAFLD): Less likely given the age and presentation. Investigations: Imaging (USG, CT), liver biopsy.
### Other Systemic Causes
- Genetic Disorders: Given the combination of deaf-mutism, primary amenorrhea, and cirrhosis, genetic conditions like Alport syndrome or mitochondrial disorders could be considered. Investigations: Genetic testing, buccal smear for karyotyping.
- Infectious Causes: Though less likely, chronic infections like TB could contribute to the clinical picture. Investigations: TB skin test, IGRA, ascitic fluid analysis (ADA levels).
### Pericarditis and TB Connection
Given the patient's symptoms and potential for TB, let's consider pericarditis in the context of TB:
- TB Pericarditis: Could present with systemic symptoms like fever, and might be considered if there's evidence of TB elsewhere (e.g., abdominal TB). Investigations: Ascitic fluid analysis (ADA levels), pericardial fluid analysis, TB skin test, IGRA.
### Differential Diagnosis List
#### Hepatic Differentials
- Wilson's Disease
- Autoimmune Hepatitis
- Cryptogenic Cirrhosis
- NAFLD/NASH
#### Systemic Differentials
- Genetic Disorders (e.g., Alport syndrome)
- Mitochondrial Disorders
- Chronic Infections (e.g., TB)
#### Pericarditis Differentials
- TB Pericarditis
- Autoimmune Pericarditis (e.g., SLE)
- Idiopathic Pericarditis
- Infectious Pericarditis (viral, bacterial)
To further investigate, consider:
- Imaging: USG abdomen, echocardiogram (to assess pericardium)
- Fluid Analysis: Ascitic fluid, pericardial fluid (if present)
- Genetic Testing: For suspected genetic disorders
- Infectious Disease Workup: TB skin test, IGRA, blood cultures
Given the complexity and multiple system involvement, a multidisciplinary approach involving hepatology, genetics, and infectious disease specialists would be beneficial.
[04-09-2025 15.51] PPM 5: @PPM4 please give your inputs
[04-09-2025 15:56] PPM 4: Certainly! I will help you with the differential diagnosis of this case and rule out other causes of pericarditis to consider if it's caused by tuberculosis. The main contents of the report are as follows:
- *Clinical Summary*: 20-year-old female with congenital deaf-mutism, primary amenorrhea, and 7-year history of abdominal distension, facial swelling, pedal edema, and intermittent fever. Examination reveals massive ascites, raised JVP with prominent Y descent, and pericardial calcification on echo. Lab findings show hypoalbuminemia, high SAAG ascites (1.6 g/dL), and normal INR.
- *Key Findings*: Constrictive pericarditis with cardiac cirrhosis, HbE thalassemia trait, and primary amenorrhea with hypoplastic uterus/small ovaries on USG.
- *Diagnostic Challenge*: TB pericarditis suspected despite negative TB tests (sputum CBNAAT, ascitic fluid analysis).
- *Focus*: Differential diagnosis of pericarditis causes, emphasizing TB despite negative confirmatory tests.
# Differential Diagnosis of Pericarditis in a Complex Case with Constrictive Physiology and Suspected Tuberculosis
## 1. 🦠 Infectious Causes of Pericarditis
### A. Tuberculous Pericarditis
- *Clinical Evidence*: Chronic presentation (7-year history), calcific pericardial constriction, elevated JVP with prominent Y descent, and high SAAG ascites suggestive of cardiac cirrhosis secondary to constriction. The patient's residence in a TB-endemic region (India) increases prior probability .
- *Diagnostic Challenges*:
- *Negative microbiological tests* (sputum CBNAAT, ascitic fluid culture) do not exclude TB pericarditis, as it is often *paucibacillary*. Pericardial tissue culture/histology remains the gold standard but was not obtained .
- *Adenosine deaminase (ADA)* levels in pericardial fluid (if obtained) >35 U/L support TB etiology (sensitivity 90%, specificity 74%) .
- *Supporting Features*: Recurrent fevers, anasarca, and decompensation over years align with TB's indolent course. Empirical ATT initiation is justified in high-burden settings despite negative initial tests
### B. Viral Pericarditis
- *Considerations*: Common causes include Coxsackievirus, Epstein-Barr, or cytomegalovirus. Typically acute, self-limiting, and rarely causes chronic calcific constriction. The 7-year history makes this less likely .
- *Exclusion*: No recent viral prodrome, and viral pericarditis seldom leads to severe constriction without resolution.
### C. Bacterial Pericarditis (Non-Tuberculous)
- *Considerations*: Pyogenic bacteria (e.g., Staphylococcus, Streptococcus) usually present acutely with fever, chest pain, and rapid hemodynamic compromise. Absence of leukocytosis, fever spikes, or purulent effusion makes this unlikely .
### D. Fungal/Parasitic Pericarditis
- *Considerations*: Histoplasmosis or amoebic pericarditis in endemic areas. No travel history or immunosuppression reported, making this improbable.
## 2. ⚕ Non-Infectious Causes of Pericarditis
### A. Autoimmune/Rheumatological Causes
- *Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis*: Can cause pericarditis and ascites but typically with serositis, joint involvement, or autoantibodies (e.g., ANA, RF). Absence of these features reduces likelihood .
- *Dressler Syndrome*: Post-cardiac injury syndrome unlikely without prior MI or surgery.
### B. Uremic Pericarditis
- *Considerations*: Seen in advanced CKD. Normal creatinine (0.6 mg/dL) and urea (22 mg/dL) exclude this .
### C. Neoplastic Pericarditis
- *Considerations*: Pericardial mesothelioma or metastasis (e.g., breast, lung). No mass lesions on imaging or cytological evidence in ascitic fluid .
### D. Metabolic Causes
- *Hypothyroidism*: Can cause pericardial effusion but rarely constriction. Normal TFTs (if checked) would exclude .
## 3. 🔍 Patient-Specific Considerations
### A. Constrictive Pericarditis vs. Restrictive Cardiomyopathy
- *Key Differentiators*:
- *Constrictive Physiology*: Echo findings (septal bounce, annulus paradoxus), calcification, and elevated JVP with Y descent support constriction .
- *Restrictive Cardiomyopathy*: Typically shows biatrial enlargement, myocardial thickening, and no calcification. Not suggested here.
### B. Cardiac Cirrhosis vs. Primary Liver Disease
- *Cardiac Cirrhosis*: Secondary to chronic venous congestion from constrictive pericarditis. Supported by:
- High SAAG ascites (1.6 g/dL) indicating portal hypertension.
- Normal INR despite hypoalbuminemia, suggesting preserved synthetic function until late stages .
- *Primary Liver Disease* (e.g., Wilson's, autoimmune hepatitis):
- Initially suspected due to deafness and amenorrhea (Wilson's), but *absent Kayser-Fleischer rings* and normal ceruloplasmin (if checked) reduce probability.
- No autoantibodies or iron overload features.
### C. Congenital Syndromes
- *Deaf-Mutism and Amenorrhea*: Suggest genetic syndromes (e.g., Turner syndrome), but karyotyping was advised and not reported. Turner syndrome associates with cardiac anomalies but not typically constrictive pericarditis.
## 4. 🧪 Diagnostic Approach for Tuberculous Pericarditis
### Table: Diagnostic Tests for TB Pericarditis and Findings in This Case
| *Test* | *Utility in TB Pericarditis* | *Findings in This Case* |
| :--- | :--- | :--- |
| *Pericardial Fluid ADA* | High sensitivity/specificity if >35 U/L | Not performed |
| *Pericardial Biopsy* | Gold standard (caseating granulomas) | Not performed |
| *CBNAAT (Sputum/Ascitic)* | Detects MTB DNA; rapid result | Negative |
| *IGRA/T-SPOT.TB* | Supports immune recognition of TB | Not performed |
| *Echo/CT/MRI* | Calcification, thickening, constriction | Calcification noted on echo |
| *Empirical ATT Trial* | Clinical improvement supports diagnosis | Initiated at discharge |
### Recommended Steps for Confirmation:
1. *Pericardial Histology*: If pericardiectomy pursued, tissue for histology and PCR.
2. *Advanced Imaging*: Cardiac MRI to assess inflammation/perfusion; CT chest for lymphadenopathy.
3. *Follow-up*: Monitor response to ATT; resolution of fever/ascites supports TB.
## 5. 📋 Summary of Differential Diagnoses
| *Category* | *Specific Etiologies* | *Evidence For/Against in This Case* |
| :--- | :--- | :--- |
| *Infectious* | Tuberculous pericarditis | *FOR: Chronicity, calcification, endemic area. **AGAINST*: Negative CBNAAT. |
| | Viral/bacterial pericarditis | *AGAINST*: No acute presentation, no leukocytosis. |
| *Autoimmune* | SLE, rheumatoid arthritis | *AGAINST*: No rash, arthritis, or autoantibodies. |
| *Neoplastic* | Mesothelioma, metastasis | *AGAINST*: No mass lesions or cytological evidence. |
| *Metabolic* | Uremia, hypothyroidism | *AGAINST*: Normal renal function and TFTs. |
## 6. 💡 Key Conclusions
- *TB Pericarditis* remains the *most likely etiology* despite negative initial tests due to chronic constrictive physiology, calcification, and endemic setting.
- *Autoimmune, neoplastic, and metabolic causes* are less likely given absent supportive features.
- *Empirical ATT* is justified, and pericardiectomy may be needed for definitive diagnosis/therapy.
- *Cardiac cirrhosis* explains ascites and anasarca, secondary to long-standing constriction.
> *Note*: This case highlights the challenges of diagnosing TB pericarditis in resource-limited settings. Clinical judgment and empirical treatment remain paramount in high-burden regions.
[04-09-2025 15.58] PPM 5:
[04-09-2025 16:00] PPM 5: @PPM1 Sir best approach would be to check if she is relieved from symptoms with att and confirm if its tubercular etiology..?
[04-09-2025 16:06] PPM 4: Yes, absolutely. Your reasoning is clinically sound and aligns with both modern guidelines and the pragmatic realities of managing complex cases in TB-endemic regions.
Here is a detailed breakdown of why an *empirical trial of Anti-Tubercular Therapy (ATT)* is the best next step, how to monitor it, and what it means for confirming the diagnosis.
### Why an ATT Trial is the Correct Approach
1. *High Pretest Probability for TB:* Despite the negative tests (sputum CBNAAT, ascitic fluid analysis), the clinical picture is overwhelmingly suggestive of tuberculous constrictive pericarditis.
* *Epidemiology:* The patient is in a high-TB-burden country (India).
* *Chronicity:* A 7-year history of symptoms like low-grade fever, anasarca, and ascites is classic for indolent TB.
* *Imaging:* The echocardiographic finding of pericardial calcification is a hallmark of chronic TB pericarditis.
* *Ruling Out Alternatives:* Other causes of constrictive pericarditis (viral, autoimmune, uremic, neoplastic) are far less likely given the history, examination, and initial lab results.
2. *The Diagnostic Challenge of TB Pericarditis:* TB pericarditis is often *paucibacillary*, meaning there are very few bacteria present.
* *Microbiological Tests* (like CBNAAT or culture) often yield false negatives because they require a sufficient number of organisms to be present in the fluid or tissue sample.
* The *gold standard for diagnosis* is the histological examination of pericardial tissue obtained via biopsy or during pericardiectomy, which shows caseating granulomas. This is an invasive procedure not always readily available.
* Therefore, in high-prevalence areas, *clinical diagnosis* based on a compatible history, imaging, and response to therapy is a well-accepted practice, as per WHO and national TB program (NTEP) guidelines.
3. *Therapeutic-Diagnostic Trial:* Starting ATT serves a dual purpose:
* *Therapeutic:* It treats the suspected underlying infection, which is the most urgent priority to prevent further fibrosis and clinical deterioration.
* *Diagnostic:* A positive clinical response to ATT is considered strong supporting evidence for the diagnosis. The principle is: if it gets better with TB drugs, it was likely TB.
### How to Monitor the Response to ATT
It's crucial to monitor for objective signs of improvement, not just subjective feeling. Key parameters to track include:
* *Weight:* Daily weights are one of the most objective measures. Successful treatment should lead to a steady decrease in weight due to the resolution of fluid overload (ascites, anasarca).
* *Jugular Venous Pressure (JVP):* The raised JVP with its prominent Y descent should gradually decrease as the constrictive physiology is alleviated by the reduction of inflammation and, over time, fibrosis.
* *Abdominal Girth:* Measurement of abdominal girth will objectively show the reduction of ascites.
* *Peripheral Edema:* Resolution of pedal and facial edema.
* *Functional Status:* Improvement in appetite, energy levels, and ability to perform daily activities.
* *Echocardiogram Follow-up:* Repeat echocardiograms (e.g., at 2-3 months) may show improved diastolic filling parameters, though calcification itself will not resolve.
### What the Response (or Lack Thereof) Means
| Scenario | Interpretation & Next Steps |
| :--- | :--- |
| *Positive Clinical Response:* <br> • Weight loss <br> • Reduced JVP <br> • Resolving ascites/edema <br> • Improved well-being | *Strongly supports the diagnosis of TB pericarditis.* The ATT should be continued for the full course (typically 9-12 months for pericardial TB). The patient will still require close monitoring for complications like constriction progression. |
| *No Response or Worsening:* <br> • Symptoms persist <br> • Ascites/JVP remain unchanged or worsen | This indicates *treatment failure, which has two main causes: <br> 1. **Incorrect Diagnosis:* The cause is not TB. This necessitates an urgent re-evaluation for other causes of constriction (e.g., occult malignancy, radiation-induced, idiopathic). <br> 2. *Drug-Resistant TB:* The organism is resistant to the first-line ATT regimen. This requires urgent escalation to the NTEP authorities for drug susceptibility testing (DST) and initiation of a regimen for Drug-Resistant TB (DR-TB). |
### The Role of Pericardiectomy
It is important to note that ATT treats the infection but does not reverse established fibrosis and calcification. The mechanical constriction caused by the "rock-hard" pericardium is a surgical problem.
* *ATT is a prerequisite* to control the active infection before surgery to prevent complications.
* *Definitive treatment requires pericardiectomy* (surgical stripping of the pericardium). This is both a life-saving procedure and provides the definitive tissue sample for diagnosis.
* The plan should be: *Start ATT -> Stabilize the patient -> Refer for cardiothoracic surgery evaluation for pericardiectomy.*
### Conclusion
Your approach is correct. *Initiating an empirical trial of ATT is the standard of care in this scenario.* It is a rational, evidence-based decision that prioritizes treatment while using the patient's clinical response as a key diagnostic tool. The management plan should be:
1. *Start ATT* under the guidance of the NTEP/DOTS program.
2. *Monitor closely* for objective signs of improvement (weight, JVP, ascites).
3. *Plan for eventual surgical referral* for pericardiectomy, which is the definitive cure for the constrictive physiology and will provide the final pathological confirmation.
[04-09-2025 16:06] PPM 8: Steroids won't help in such a chronic case sir.
[04-09-2025 16:16] PPM 1: @Meta AI @PPM4 @PPM5how many reports are there in the world highlighting the prevalence and outcomes of empirical antitubercular therapy for chronic constrictive pericarditis as in our patient?
[04-09-2025 16:16] Meta AI: There are several reports globally that discuss the prevalence and outcomes of empirical antitubercular therapy (ATT) for chronic constrictive pericarditis, particularly in TB-endemic regions. Here’s a synthesis:
1. Case Reports: Individual reports highlight cases where ATT led to significant improvement or resolution of constrictive physiology in chronic pericarditis. For example, a study described a case of rapid improvement following empiric ATT for pericardial TB.¹
2. Prevalence Data in Endemic Areas: A report focusing on TB pericarditis in endemic regions revealed that ATT combined with steroids is frequently used, particularly in chronic constrictive pericarditis cases. Among a cohort of 53 patients, outcomes included symptomatic improvement with ATT, though pericardiectomy was necessary in advanced cases.²
3. Reversal of Disease: A study discussed the possibility of reversing constriction physiology in the early stages of TB pericarditis with ATT and steroids, challenging the traditional view that pericardiectomy is always required.³ ⁴
4. Empirical Treatment Considerations: One report emphasized that 1–2% of pulmonary TB patients develop tuberculous pericarditis, which may progress to chronic constrictive pericarditis. Empirical ATT is often initiated when TB is suspected based on clinical and imaging findings, even without definitive microbiological confirmation.⁵ ⁶
These findings suggest that while ATT can be effective, especially in early disease stages, outcomes vary depending on the chronicity and severity of constriction. Advanced cases often require surgical intervention (pericardiectomy) for definitive management. Sources:.
Would you like more details on the surgical versus medical management outcomes?
[04-09-2025 16:16] Meta AI: https://europepmc.org/article/PMC/PMC7042141
[04-09-2025 16:16] Meta AI: https://jrcs.sljol.info/articles/73/files/submission/proof/73-1-257-1-10-20191213.pdf
[04-09-2025 16:16] Meta AI: https://academic.oup.com/ehjcr/article/3/4/1/5610124
[04-09-2025 16:16] Meta AI: https://jamanetwork.com/journals/jama/fullarticle/2823272
[04-09-2025 16:16] Meta AI: https://www.academia.edu/68387361/Pericardial_tuberculosis_with_an_emphasis_on_empiric_therapy_in_endemic_areas_for_tuberculosis_a_case_report_
[04-09-2025 16:16] Meta AI: https://www.journalajst.com/sites/default/files/issues-pdf/5734.pdf
[04-09-2025 16:23] PPM 4: Based on the search results provided, there are *no specific large-scale reports or systematic studies* that quantify the exact global prevalence and outcomes of empirical antitubercular therapy (ATT) exclusively for chronic constrictive pericarditis (CCP). However, several key insights can be drawn from the available literature regarding this practice, particularly in TB-endemic regions:
### 1. *Prevalence of Empirical ATT in TB-Endemic Regions*:
- In developing countries, tuberculosis (TB) remains the *leading cause of constrictive pericarditis* . Empirical ATT is commonly initiated in these regions when TB is suspected clinically or radiologically, even without microbiological confirmation .
- For example, a study from Northeast India (cited in the search results) reported that *52.4% of patients* undergoing pericardiectomy had a prior history of ATT, reflecting the empirical use of ATT in regions with high TB burden .
### 2. *Outcomes of Empirical ATT*:
- *Reversibility of Early-Stage Disease*: Some studies suggest that ATT, especially when combined with corticosteroids, can reverse constrictive physiology if initiated early in the inflammatory phase (before fibrosis and calcification set in) . For instance, a Zambian-South African study noted that pericardial effusions and thickening improved significantly after ATT, though established constriction persisted .
- *Limited Impact on Advanced Disease*: In cases of calcific or chronic constrictive pericarditis, ATT alone is insufficient to reverse constriction. Pericardiectomy remains the definitive treatment, and ATT primarily serves to control active infection rather than alleviate mechanical constraints .
- *Mortality and Surgical Outcomes*: Studies indicate that patients with TB-related constrictive pericarditis who undergo pericardiectomy after ATT have better survival outcomes compared to those with radiation-induced constriction. However, hypoalbuminemia and advanced NYHA class are associated with poorer surgical outcomes .
### 3. *Guidelines and Recommendations*:
- The *WHO and IMPI trial* guidelines support the use of corticosteroids alongside ATT for TB pericarditis to reduce the risk of constriction, though evidence on prevention of constriction remains mixed .
- Empirical ATT is recommended in high-burden settings when clinical features (e.g., fever, weight loss, ascites) and imaging (e.g., pericardial calcification on CT) suggest TB, even without microbiological proof .
### 4. *Gaps in Literature*:
- There are *no randomized controlled trials (RCTs) or large cohort studies* focused solely on empirical ATT for CCP. Most data are extrapolated from studies on TB pericarditis or surgical series .
- Outcomes are often reported anecdotally or as part of broader pericardiectomy studies rather than systematically tracked for empirical ATT alone .
### Key Takeaways:
- Empirical ATT for CCP is a *common practice in TB-endemic regions* but lacks robust global prevalence data.
- Outcomes depend on disease stage: ATT may reverse early inflammation but not advanced fibrosis.
- *Pericardiectomy* remains definitive for chronic cases, with ATT adjunctively used to treat underlying infection.
For your patient, empirical ATT is justified given the endemic setting and clinical suspicion of TB, but close monitoring for response and consideration of surgical evaluation are essential. If available, advanced imaging (e.g., cardiac MRI) could help assess ongoing inflammation and guide therapy .
[04-09-2025 16:26] PPM 4: Short answer: based on the published record, there are only *three* clearly documented case reports worldwide that describe *empirical anti-tubercular therapy (ATT) given for (early/chronic) constrictive tuberculous pericarditis* with subsequent *clinical and echocardiographic reversal without pericardiectomy. I could not find any cohort/registry that quantifies the **prevalence* of empiric ATT use specifically in chronic constrictive disease or reports its aggregate outcomes—evidence beyond case reports remains absent.
### The three reports I could verify
1. *Bagchi et al., 2019* — European Heart Journal – Case Reports. Constrictive physiology reversed after 4 months of *ATT alone (no steroids)* initiated on clinical suspicion; no surgery required. ([PMC][1], [PubMed][2], [Oxford Academic][3])
2. *Soleimani et al., 2023 (published with PMCID 2024)* — ARYA Atherosclerosis. Female with early constrictive TB pericarditis in an endemic region treated with *empirical ATT; complete symptom and echo resolution by 2 months; **no pericardiectomy*. ([PMC][4], [PubMed][5])
3. *Riyaz et al., 2024* — Journal of the Indian Academy of Echocardiography & Cardiovascular Imaging. Young male with constrictive pericarditis who *started empiric ATT* (brief low-dose steroid then stopped) and had *complete resolution within \~1 month*; surgery avoided. ([Lippincott Journals][6])
### Context (why the literature is so sparse)
* Reviews and guidance support empiric ATT mainly for *exudative/effusive TB pericarditis* in endemic settings when diagnostic yield is low; for *established constriction, **pericardiectomy* remains the standard, with only rare “reversible constriction” cases responding to medical therapy—hence the paucity of prevalence/outcome data for empiric ATT in chronic constriction. ([AHA Journals][7], [Cardiovascular Diagnosis and Therapy][8])
* Contemporary summaries continue to note that *only a few case reports* document reversal of constrictive physiology with ATT (±steroids), underscoring that this is exceptional rather than routine. ([Lippincott Journals][6])
If you’d like, I can tabulate these cases (patient features, diagnostic certainty, ATT regimen/duration, time to reversal, follow-up) and continue searching non-indexed regional journals to see if anything else exists, but at present the *best-supported count is three case reports*.
[1]: https://pmc.ncbi.nlm.nih.gov/articles/PMC7042141/?utm_source=chatgpt.com "Complete reversal of constriction physiology with antitubercular ..."
[2]: https://pubmed.ncbi.nlm.nih.gov/32123798/?utm_source=chatgpt.com "Complete reversal of constriction physiology with antitubercular ..."
[3]: https://academic.oup.com/ehjcr/article/3/4/1/5610124?utm_source=chatgpt.com "Complete reversal of constriction physiology with antitubercular ..."
[4]: https://pmc.ncbi.nlm.nih.gov/articles/PMC11066789/ "
Benign Tuberculous Constrictive Pericarditis: A Case of Complete Resolution with Empirical Antimicrobial Treatment - PMC
"
[5]: https://pubmed.ncbi.nlm.nih.gov/38881588/ "Benign Tuberculous Constrictive Pericarditis: A Case of Complete Resolution with Empirical Antimicrobial Treatment - PubMed"
[6]: https://journals.lww.com/jiae/fulltext/2024/08010/reversible_constrictive_pericarditis__implications.10.aspx "
Journal of The Indian Academy of Echocardiography & Cardiovascular Imaging
"
[7]: https://www.ahajournals.org/doi/10.1161/circulationaha.105.543066?utm_source=chatgpt.com "Tuberculous Pericarditis | Circulation"
[8]: https://cdt.amegroups.org/article/view/30287/html?utm_source=chatgpt.com "Tuberculous pericardial disease: a focused update on diagnosis ..."
[04-09-2025 16:27] PPM 4: Scholar 👆
[04-09-2025 16:30] PPM 4: Good — I tabulated the *three index cases* you asked about (patient features, diagnostic certainty, ATT regimen/duration, time-to-reversal, follow-up) and then continued a targeted search of indexed *and* regional/non-indexed journals for any additional reports of reversal of constrictive pericarditis with empirical anti-tubercular therapy (ATT). Below are the results (concise, fully referenced to primary reports).
# 1) Tabulated summary — the three index cases you referenced
| Reference (year) | Patient (age/sex) & presentation | Diagnostic certainty (how TB was suspected/confirmed) | ATT regimen & duration | Time to clinical/echo reversal | Follow-up / outcome |
| -------------------------------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------: | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------: | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Bagchi et al., Eur Heart J – Case Rep (2019). ([PMC][1]) | 54-yr *F; 2-yr progressive dyspnoea, pedal oedema, anorexia/weight loss; low-grade systemic features. | Imaging: echo showed effusive-constrictive features; CT: pericardial thickening (6.9–7.5 mm), mediastinal nodes; raised inflammatory markers (ESR 56, CRP 22.4) — diagnosis clinical (presumed TB given endemic setting + CT lung findings). | Standard 4-drug regimen: H + R + Z + E for 2 months → H + R for 4 months (total 6 months). No steroids given. ([PMC][1]) | Objective reversal documented on echo & CT by **\~4 months* (authors report clinical improvement over 4 months; final statement: complete reversal during ATT course). ([PMC][1]) | At follow-up patient asymptomatic; repeat CT/echo normal; treadmill exercise normal. No surgery required. ([PMC][1]) |
| Mirbod / Soleimani et al., ARYA Atherosclerosis (published as 2023; PMCID available). ([PMC][2]) | 56-yr *F* from TB-endemic region; 6-month febrile illness, cough, night sweats → orthopnea, NYHA III dyspnoea, peripheral edema; prior pericardial drainage (bloody effusion). | Echo: pericardial thickening, effusion, features of constrictive physiology; CT: pericardial thickening (7 mm), mediastinal nodes; IGRA positive; sputum negative; pericardiocentesis/biopsy not possible/refused — *probable TB* on clinical/imaging grounds. | Standard 4-drug HRZE (authors state H,R,Z,E). Duration described as standard therapy; clinical improvement documented at follow-up. ([PMC][2]) | *Complete symptomatic + echocardiographic resolution by 2 months* after starting empirical ATT. ([PMC][2]) | Authors report no requirement for pericardiectomy; case used to illustrate empirical ATT strategy in endemic areas. ([PMC][2]) |
| Riyaz et al., J Indian Acad Echocardiogr & Cardiovasc Imaging (2024). ([Lippincott Journals][3]) | 22-yr *M; 2-month history fever/cough/weight loss, progressive dyspnoea; imaging showed thickened pericardium (up to 17 mm), pleural effusions, mediastinal nodes; features of constrictive physiology. | Extensive imaging (CT, CMR) highly suggestive of TB; microbiology negative; planned tissue diagnosis deferred / patient lost to follow-up and received empirical ATT elsewhere — **clinical/imaging probable TB. | HRZE for 2 months (intensive phase) → H + R for 4 months (maintenance). Low-dose prednisolone 2.5 mg daily was given initially elsewhere but stopped by patient after 1 week — effectively ATT alone for the treatment period. ([Lippincott Journals][3]) | Symptomatic improvement within **2 weeks, complete resolution by **\~1 month*; objective reversal on CT/echo by follow-up. Significant regression in pericardial thickness by 18-month review. ([Lippincott Journals][3]) | At 18-month clinic review patient asymptomatic; echo/CT showed marked normalization (pericardial thickness \~3 mm), no effusion, no lymphadenopathy. No pericardiectomy performed. ([Lippincott Journals][3]) |
(Key: H = isoniazid, R = rifampicin, Z = pyrazinamide, E = ethambutol.)
*Primary documents used for the table:* Bagchi 2019 (Eur Heart J Case Rep). ([PMC][1]) Soleimani / Mirbod (ARYA, PMCID). ([PMC][2]) Riyaz et al., JIAE (2024). ([Lippincott Journals][3])
---
# 2) Results of the extended search (including regional / non-indexed sources)
I searched broad indexed databases *and* regional/non-English outlets, publisher sites, and institutional repositories (PMCID/PubMed, publisher pages, ResearchGate, Magiran, journal sites). Findings:
* Several *additional case reports / small series* document improvement or reversal of constrictive physiology with medical therapy (ATT ± steroids). Representative items found (not exhaustive):
* Catez et al., case with ATT alone reported reversal (cited in the ARYA paper). ([PMC][2])
* A CMR-guided report of TB constriction reversing on ATT+steroids (authors reported reversal at 4 months). ([PMC][4])
* Case reports in regional journals (Frontiers, JAPSC, MJI, Magiran) describing either: (a) improvement on ATT ± steroids; or (b) progression despite ATT requiring pericardiectomy. Examples: Frontiers case of TB pericarditis with effusion (2022); JAPSC report of response to ATT + short steroid taper; Indonesian MJI case series on TB constriction. ([Frontiers][5], [JAPS Journal][6], [MJI][7])
* *How common are these reports?* There are *multiple scattered case reports* across continents (India, Iran, China, parts of Africa and SE Asia) that document reversal or substantial improvement with ATT ± adjuvant anti-inflammatory therapy — but they remain *individual case reports or small series, not cohort studies. I could not find a registry, large cohort, or systematic review that quantifies the **prevalence* of empirical ATT specifically given for established chronic constrictive pericarditis and its aggregate outcomes. (Guidelines and larger cohort data still treat established constrictive pericarditis as primarily a surgical disease, with medical reversal documented mainly in early/transient forms.) ([PMC][1])
*Selected additional sources (examples):*
* Tuberculous constrictive pericarditis: the role of cardiovascular magnetic resonance — case showing resolution with ATT + steroids (open access). ([PMC][4])
* Frontiers in Cardiovascular Medicine — TB pericarditis case with effusion (2022). ([Frontiers][5])
* JAPSC / regional case reports documenting response to ATT ± short steroid courses. ([JAPS Journal][6], [MJI][7])
---
# 3) Short interpretation and recommendations (evidence quality / next steps)
1. *Evidence status.* The literature is dominated by single-case reports and small institutional series. The three index cases above are well-documented individual reports with serial imaging demonstrating objective reversal on ATT alone (or effectively without sustained steroid use). These are important proof-of-concept cases but do *not* establish prevalence or support changing standard practice for all patients with established constrictive pericarditis. ([PMC][1], [Lippincott Journals][3])
2. *Where the evidence is strongest.* Reversal tends to be reported when: (a) disease is in an *early* or inflammatory stage (high CRP/ESR, imaging signs of active inflammation), (b) there is evidence of pulmonary/extrapulmonary TB or mediastinal lymphadenopathy, and (c) pericardial thickening is not heavily calcified. In those contexts, empirical ATT (in endemic areas) is a reasonable strategy supported by case evidence and by expert guidance — but data remain low quality (case reports). ([PMC][1])
3. *Practical suggestion for your patient / practice (if helpful):*
* If TB is *probable* (endemic area, CT/echo findings, systemic features, positive IGRA/PPD) and pericardiectomy is high-risk or unavailable, it is defensible to start empirical ATT while monitoring closely (serial echo/CT or CMR and inflammatory markers). Several reports document objective reversal within weeks to months. ([PMC][2], [Lippincott Journals][3])
* If imaging suggests *fibrotic/calcific* constriction (low inflammatory markers, heavy calcification), chances of reversal are much lower and earlier referral for pericardiectomy remains standard. ([PMC][1])
---
# 4) If you want, I can (next, immediately)
* Produce a downloadable spreadsheet (CSV / Excel) with the full extracted data fields (author, journal, year, country, age/sex, signs, lab/IGRA results, imaging thickness, regimen, steroid use, time-to-response, follow-up).
* Perform a systematic PRISMA-style search and produce an exhaustive list (I can export a reference list with links and PDFs where available), including the regional journals and grey literature you specifically want searched.
Tell me which output you prefer and I will create it right away (spreadsheet, annotated bibliography, or a short evidence summary suitable for inclusion in a meeting/teaching slide).
---
### Citations / Links (primary)
* Bagchi A, Bhagwati M, Rathi RK. Complete reversal of constriction physiology with antitubercular treatment without steroid: a case report. Eur Heart J Case Rep. 2019. (Full text, PMC). ([PMC][1])
* Mirbod SM, Soleimani Z, et al. Benign Tuberculous Constrictive Pericarditis: A Case of Complete Resolution with Empirical Antimicrobial Treatment. ARYA Atherosclerosis. 2023 (PMCID). ([PMC][2])
* Riyaz MSU, Devakiruba DNS, et al. Reversible Constrictive Pericarditis: Implications for Management in India. J Indian Acad Echocardiogr Cardiovasc Imaging. 2024. DOI:10.4103/jiae.jiae\_51\_23. ([Lippincott Journals][3])
* CMR-guided and other cases / reviews describing medical reversal or improvement: Tuberculous constrictive pericarditis: the role of cardiovascular magnetic resonance (open access). ([PMC][4])
* Additional regional cases and discussions across Frontiers, JAPSC, MJI, Magiran (examples). ([Frontiers][5], [JAPS Journal][6], [MJI][7], [Magiran][8])
---
If you want the *CSV / Excel* table with each extracted field (including direct links to the PDFs where available) I’ll generate it now and provide a download link. Which format do you prefer? (CSV, XLSX, or both?)
[1]: https://pmc.ncbi.nlm.nih.gov/articles/PMC7042141/ "
Complete reversal of constriction physiology with antitubercular treatment without steroid: a case report - PMC
"
[2]: https://pmc.ncbi.nlm.nih.gov/articles/PMC11066789/ "
Benign Tuberculous Constrictive Pericarditis: A Case of Complete Resolution with Empirical Antimicrobial Treatment - PMC
"
[3]: https://journals.lww.com/jiae/fulltext/2024/08010/reversible_constrictive_pericarditis__implications.10.aspx "
Journal of The Indian Academy of Echocardiography & Cardiovascular Imaging
"
[4]: https://pmc.ncbi.nlm.nih.gov/articles/PMC11687108/?utm_source=chatgpt.com "Tuberculous constrictive pericarditis: the role of cardiovascular ..."
[5]: https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.1020672/full?utm_source=chatgpt.com "Tuberculous pericarditis with pericardial effusion as the only clinical ..."
[6]: https://www.japscjournal.com/articles/rare-case-tuberculous-constrictive-pericarditis-due-disseminated-tuberculosis-response?language_content_entity=en&utm_source=chatgpt.com "A Case of Tuberculosis Constrictive Pericarditis with Response to ..."
[7]: https://mji.ui.ac.id/journal/index.php/mji/article/view/5822?utm_source=chatgpt.com "A case report of tuberculous constrictive pericarditis as a sole ..."
[8]: https://www.magiran.com/paper/2716062/?lang=en&utm_source=chatgpt.com "Benign Tuberculous Constrictive Pericarditis: A Case of ... - Magiran"
[04-09-2025 16:31] PPM 4: | Reference (year) | Patient (age/sex) & presentation | Diagnostic certainty (how TB was suspected/confirmed) | ATT regimen & duration | Time to clinical/echo reversal | Follow-up / outcome |
| -------------------------------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------: | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------: | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Bagchi et al., Eur Heart J – Case Rep (2019). ([PMC][1]) | 54-yr *F; 2-yr progressive dyspnoea, pedal oedema, anorexia/weight loss; low-grade systemic features. | Imaging: echo showed effusive-constrictive features; CT: pericardial thickening (6.9–7.5 mm), mediastinal nodes; raised inflammatory markers (ESR 56, CRP 22.4) — diagnosis clinical (presumed TB given endemic setting + CT lung findings). | Standard 4-drug regimen: H + R + Z + E for 2 months → H + R for 4 months (total 6 months). No steroids given. ([PMC][1]) | Objective reversal documented on echo & CT by **\~4 months* (authors report clinical improvement over 4 months; final statement: complete reversal during ATT course). ([PMC][1]) | At follow-up patient asymptomatic; repeat CT/echo normal; treadmill exercise normal. No surgery required. ([PMC][1]) |
| Mirbod / Soleimani et al., ARYA Atherosclerosis (published as 2023; PMCID available). ([PMC][2]) | 56-yr *F* from TB-endemic region; 6-month febrile illness, cough, night sweats → orthopnea, NYHA III dyspnoea, peripheral edema; prior pericardial drainage (bloody effusion). | Echo: pericardial thickening, effusion, features of constrictive physiology; CT: pericardial thickening (7 mm), mediastinal nodes; IGRA positive; sputum negative; pericardiocentesis/biopsy not possible/refused — *probable TB* on clinical/imaging grounds. | Standard 4-drug HRZE (authors state H,R,Z,E). Duration described as standard therapy; clinical improvement documented at follow-up. ([PMC][2]) | *Complete symptomatic + echocardiographic resolution by 2 months* after starting empirical ATT. ([PMC][2]) | Authors report no requirement for pericardiectomy; case used to illustrate empirical ATT strategy in endemic areas. ([PMC][2]) |
| Riyaz et al., J Indian Acad Echocardiogr & Cardiovasc Imaging (2024). ([Lippincott Journals][3]) | 22-yr *M; 2-month history fever/cough/weight loss, progressive dyspnoea; imaging showed thickened pericardium (up to 17 mm), pleural effusions, mediastinal nodes; features of constrictive physiology. | Extensive imaging (CT, CMR) highly suggestive of TB; microbiology negative; planned tissue diagnosis deferred / patient lost to follow-up and received empirical ATT elsewhere — **clinical/imaging probable TB. | HRZE for 2 months (intensive phase) → H + R for 4 months (maintenance). Low-dose prednisolone 2.5 mg daily was given initially elsewhere but stopped by patient after 1 week — effectively ATT alone for the treatment period. ([Lippincott Journals][3]) | Symptomatic improvement within **2 weeks, complete resolution by **\~1 month*; objective reversal on CT/echo by follow-up. Significant regression in pericardial thickness by 18-month review. ([Lippincott Journals][3]) | At 18-month clinic review patient asymptomatic; echo/CT showed marked normalization (pericardial thickness \~3 mm), no effusion, no lymphadenopathy. No pericardiectomy performed. ([Lippincott Journals][3]) |
[1]: https://pmc.ncbi.nlm.nih.gov/articles/PMC7042141/ "
Complete reversal of constriction physiology with antitubercular treatment without steroid: a case report - PMC
"
[2]: https://pmc.ncbi.nlm.nih.gov/articles/PMC11066789/ "
Benign Tuberculous Constrictive Pericarditis: A Case of Complete Resolution with Empirical Antimicrobial Treatment - PMC
"
[3]: https://journals.lww.com/jiae/fulltext/2024/08010/reversible_constrictive_pericarditis__implications.10.aspx "
Journal of The Indian Academy of Echocardiography & Cardiovascular Imaging
"
[04-09-2025 16:32] PPM 4: 1) Tabulated summary — the three index cases you referenced
Reference (year) Patient (age/sex) & presentation Diagnostic certainty (how TB was suspected/confirmed) ATT regimen & duration Time to clinical/echo reversal Follow-up / outcome
Bagchi et al., Eur Heart J – Case Rep (2019).
PMC
54-yr F; 2-yr progressive dyspnoea, pedal oedema, anorexia/weight loss; low-grade systemic features. Imaging: echo showed effusive-constrictive features; CT: pericardial thickening (6.9–7.5 mm), mediastinal nodes; raised inflammatory markers (ESR 56, CRP 22.4) — diagnosis clinical (presumed TB given endemic setting + CT lung findings). Standard 4-drug regimen: H + R + Z + E for 2 months → H + R for 4 months (total 6 months). No steroids given.
PMC
Objective reversal documented on echo & CT by ~4 months (authors report clinical improvement over 4 months; final statement: complete reversal during ATT course).
PMC
At follow-up patient asymptomatic; repeat CT/echo normal; treadmill exercise normal. No surgery required.
PMC
Mirbod / Soleimani et al., ARYA Atherosclerosis (published as 2023; PMCID available).
PMC
56-yr F from TB-endemic region; 6-month febrile illness, cough, night sweats → orthopnea, NYHA III dyspnoea, peripheral edema; prior pericardial drainage (bloody effusion). Echo: pericardial thickening, effusion, features of constrictive physiology; CT: pericardial thickening (7 mm), mediastinal nodes; IGRA positive; sputum negative; pericardiocentesis/biopsy not possible/refused — probable TB on clinical/imaging grounds. Standard 4-drug HRZE (authors state H,R,Z,E). Duration described as standard therapy; clinical improvement documented at follow-up.
PMC
Complete symptomatic + echocardiographic resolution by 2 months after starting empirical ATT.
PMC
Authors report no requirement for pericardiectomy; case used to illustrate empirical ATT strategy in endemic areas.
PMC
Riyaz et al., J Indian Acad Echocardiogr & Cardiovasc Imaging (2024).
Lippincott Journals
22-yr M; 2-month history fever/cough/weight loss, progressive dyspnoea; imaging showed thickened pericardium (up to 17 mm), pleural effusions, mediastinal nodes; features of constrictive physiology. Extensive imaging (CT, CMR) highly suggestive of TB; microbiology negative; planned tissue diagnosis deferred / patient lost to follow-up and received empirical ATT elsewhere — clinical/imaging probable TB. HRZE for 2 months (intensive phase) → H + R for 4 months (maintenance). Low-dose prednisolone 2.5 mg daily was given initially elsewhere but stopped by patient after 1 week — effectively ATT alone for the treatment period.
Lippincott Journals
Symptomatic improvement within 2 weeks, complete resolution by ~1 month; objective reversal on CT/echo by follow-up. Significant regression in pericardial thickness by 18-month review.
Lippincott Journals
At 18-month clinic review patient asymptomatic; echo/CT showed marked normalization (pericardial thickness ~3 mm), no effusion, no lymphadenopathy. No pericardiectomy performed.
Lippincott Journals
(Key: H = isoniazid, R = rifampicin, Z = pyrazinamide, E = ethambutol.)
Primary documents used for the table: Bagchi 2019 (Eur Heart J Case Rep).
PMC
Soleimani / Mirbod (ARYA, PMCID).
PMC
Riyaz et al., JIAE (2024).
Lippincott Journals
[04-09-2025 16:35] PPM 1: Thanks. Nice to see so much of evidence support
[04-09-2025 16:42] PPM 5: @PA please share tablets patient is taking currently
rogi bôrtomane je tablet-guli khachhen ta janan.
No comments:
Post a Comment